Wordt geladen...
New hope offered to reduce GVHD
In this issue of Blood, Thangavelu et al have developed a novel pharmacological approach to inhibit graft-versus-host disease (GVHD) by activating retinoid X receptor (RXR) in donor T cells.(1)
Bewaard in:
| Gepubliceerd in: | Blood |
|---|---|
| Hoofdauteur: | |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Society of Hematology
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7907725/ https://ncbi.nlm.nih.gov/pubmed/33630055 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2020009205 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|